CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $942.20 million. The enterprise value is $752.58 million.
| Market Cap | 942.20M |
| Enterprise Value | 752.58M |
Important Dates
The next confirmed earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 52.08 million shares outstanding. The number of shares has decreased by -3.64% in one year.
| Shares Outstanding | 52.08M |
| Shares Change (YoY) | -3.64% |
| Shares Change (QoQ) | -3.17% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 101.67% |
| Float | 50.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.42 |
| Forward PS | 3.29 |
| PB Ratio | 3.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.32 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 16.16 |
Financial Efficiency
Return on equity (ROE) is -55.60% and return on invested capital (ROIC) is -70.07%.
| Return on Equity (ROE) | -55.60% |
| Return on Assets (ROA) | -37.90% |
| Return on Capital (ROIC) | -70.07% |
| Revenue Per Employee | $427,855 |
| Profits Per Employee | -$284,905 |
| Employee Count | 643 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 5.35 |
Taxes
| Income Tax | -66,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +75.97% in the last 52 weeks. The beta is 1.79, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +75.97% |
| 50-Day Moving Average | 14.93 |
| 200-Day Moving Average | 10.54 |
| Relative Strength Index (RSI) | 68.16 |
| Average Volume (20 Days) | 760,517 |
Short Selling Information
The latest short interest is 3.82 million, so 7.33% of the outstanding shares have been sold short.
| Short Interest | 3.82M |
| Short Previous Month | 5.36M |
| Short % of Shares Out | 7.33% |
| Short % of Float | 7.53% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, CareDx had revenue of $275.11 million and -$183.19 million in losses. Loss per share was -$3.41.
| Revenue | 275.11M |
| Gross Profit | 173.14M |
| Operating Income | -198.38M |
| Pretax Income | -183.26M |
| Net Income | -183.19M |
| EBITDA | -175.06M |
| EBIT | -195.35M |
| Loss Per Share | -$3.41 |
Balance Sheet
The company has $216.50 million in cash and $26.89 million in debt, giving a net cash position of $189.61 million or $3.64 per share.
| Cash & Cash Equivalents | 216.50M |
| Total Debt | 26.89M |
| Net Cash | 189.61M |
| Net Cash Per Share | $3.64 |
| Equity (Book Value) | 256.23M |
| Book Value Per Share | 4.92 |
| Working Capital | 232.88M |
Cash Flow
In the last 12 months, operating cash flow was -$34.37 million and capital expenditures -$7.06 million, giving a free cash flow of -$41.43 million.
| Operating Cash Flow | -34.37M |
| Capital Expenditures | -7.06M |
| Free Cash Flow | -41.43M |
| FCF Per Share | -$0.80 |
Margins
Gross margin is 62.94%, with operating and profit margins of -72.11% and -66.59%.
| Gross Margin | 62.94% |
| Operating Margin | -72.11% |
| Pretax Margin | -66.61% |
| Profit Margin | -66.59% |
| EBITDA Margin | -63.63% |
| EBIT Margin | -71.01% |
| FCF Margin | -15.06% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.64% |
| Shareholder Yield | 3.64% |
| Earnings Yield | -19.44% |
| FCF Yield | -4.40% |
Analyst Forecast
The average price target for CareDx is $17.75, which is -1.88% lower than the current price. The consensus rating is "Buy".
| Price Target | $17.75 |
| Price Target Difference | -1.88% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of 0.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.53 |
| Piotroski F-Score | 3 |